• Users Online: 549
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Bilastine: A novel antihistamine

Gandhi Jeet, Godse Kiran, Godse Gauri

Year : 2018| Volume: 4| Issue : 1 | Page no: 3-6

   This article has been cited by
1 A highly sensitive spectrofluorimetric method for the determination of bilastine in its pharmaceutical preparations and biological fluids
Aya saad Radwan, Elkhoudary, Hadad, Fathalla Belal, Mohamed M. Salim
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2022; : 121246
[Pubmed]  [Google Scholar] [DOI]
2 Bilastine - Novel anti histamine drug for allergic rhinitis
Abhijit Trailokya, Soumen Roy
IP Indian Journal of Immunology and Respiratory Medicine. 2022; 7(1): 6
[Pubmed]  [Google Scholar] [DOI]
3 Bilastine up-dosing in chronic urticaria: A review
Kiran Godse, Murlidhar Rajagopalan, Bela Shah, Mukesh Girdhar, Kupra Shankar, Vijay Zawar, Abhishek De, Nidhi Sharma, Sushil Tahiliani, Anant Patil
Indian Journal of Drugs in Dermatology. 2022; 8(2): 55
[Pubmed]  [Google Scholar] [DOI]
4 A new simple RP-HPLC Method development, Validation and Forced degradation studies of Bilastine
Khushbu K. Patel,Arati M. Patel,C. N. Patel
Asian Journal of Pharmaceutical Analysis. 2021; : 183
[Pubmed]  [Google Scholar] [DOI]
5 1H-Benzimidazole-5-carboxamidine derivatives: design, synthesis, molecular docking, DFT and antimicrobial studies
Meryem Erol,Ismail Celik,Ozlem Temiz-Arpaci,Hakan Goker,Fatma Kaynak-Onurdag,Suzan Okten
New Journal of Chemistry. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 Effectiveness, safety, and tolerability of bilastine 20?mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial
Indrashis Podder,Anupam Das,Shouvik Ghosh,Debalina Biswas,Sujata Sengupta,Satyendra Nath Chowdhury
Dermatologic Therapy. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article